Efficacy of Polynucleotides in Peri-Orbital Rejuvenation: A Systematic Review

Clicks: 10
ID: 332038
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #109 of 125 articles by views in Aesthetic Surgery Journal Open Forum

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Periorbital ageing is characterized by dynamic wrinkles, volume loss, and dermal quality decline. Injectable polynucleotides (PN) have emerged as biostimulatory agents for periorbital rejuvenation, and this review evaluates their efficacy and safety for this indication. The review was conducted per PRISMA 2020 guidelines and registered on PROSPERO (CRD420261288052). MEDLINE and Embase were searched from inception to 30 January 2026 for studies of adults receiving injectable PN for periorbital rejuvenation; no meta-analysis was performed given anticipated heterogeneity. Six studies (five randomized split-face trials, one prospective case series; n=350) met inclusion criteria, all conducted in Korean and Thai cohorts with Fitzpatrick III-V skin and predominantly middle-aged women (80-100% female). PN produced consistent short-term improvements in crow's feet severity and dermal quality metrics, with 40-70% of treated sides achieving at least a one-grade Crow's Feet Grading Scale improvement at 12 weeks, reflecting cross-trial heterogeneity rather than a single pooled effect. In two trials (n=30 and n=215), PN was non-inferior to polycaprolactone fillers for crow's feet correction; in one trial (n=30), PN showed favorable biophysical outcomes relative to hyaluronic acid. Safety was favorable throughout, but no study followed patients beyond 6 months. In these East Asian, predominantly female cohorts, PN demonstrates short-term efficacy and a favorable safety profile through 6 months for periorbital rejuvenation. Given the small number of studies, heterogeneity, and lack of longer-term follow-up, findings should be regarded as preliminary. Generalization beyond the populations and timeframes studied awaits larger, longer-term, ethnically diverse trials with direct comparison to established modalities.
Reference Key
openalex_W7221329549 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rhea Ahuja, Samar Khalil, Hassan Galadari, Stefania Guida
Are you one of these authors? Claim your profile
Journal Aesthetic Surgery Journal Open Forum
Year 2026
DOI
10.1093/asjof/ojag200
URL
https://academic.oup.com/asjopenforum/advance-article-pdf/doi/10.1093/asjof/ojag200/71816233/ojag200.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.